Bone Marrow Transplant

Overview

A bone marrow transplant is a procedure that replaces damaged or diseased bone marrow with healthy stem cells, restoring the body's ability to produce the blood cells it needs to function and fight illness. Also referred to as a haematopoietic stem cell transplant, it is one of the most significant and life-altering interventions available in haematological and oncological medicine. Bone marrow is the spongy tissue found at the centre of bones. Its red marrow contains blood stem cells responsible for generating white blood cells, red blood cells, and platelets. When this system is compromised, whether by disease, aggressive cancer treatment, or a genetic condition, the consequences for overall health are profound. A transplant restores this foundation. Replacement stem cells may come from the patient's own body (autologous) or from a compatible donor (allogeneic). The approach selected depends on the underlying condition, the patient's overall health, and donor availability. GHO connects patients with internationally accredited transplant centres and highly experienced haematologists across India, one of the world's most respected destinations for bone marrow transplantation, managing every aspect of the journey with clinical precision and personal care.

Why India for Bone Marrow Transplantation

India has earned its position as a globally trusted destination for bone marrow transplantation, offering a combination of clinical expertise, advanced infrastructure, and cost efficiency that few countries can match.

India's leading transplant centres are equipped with state-of-the-art technology and staffed by surgeons and haematologists with decades of experience managing complex, high-risk cases. The majority of these hospitals carry NABH, NABL, and JCI accreditation, the same international quality benchmarks recognised by healthcare systems in the United States, United Kingdom, and Europe.

The cost of bone marrow transplantation in India is substantially lower than in Western countries, covering not only the procedure itself but also the standard of accommodation, outpatient consultations, and support services. This affordability comes without any reduction in the quality of care delivered.

International patients consistently report a high standard of holistic care throughout their stay, from initial admission through to post-transplant monitoring. GHO works exclusively with institutions that meet this standard, ensuring patients travel with complete confidence in the care they will receive.

India Medical Visa: What Patients Need to Know

India's medical visa is designed to facilitate straightforward access to treatment for international patients. Key provisions include:

• The standard India e-Medical Visa is valid for 60 days from the date of arrival and permits three entries into India.
• Where treatment extends beyond 60 days, a paper-based medical visa can be issued and extended for up to 180 days.
• Applications are completed online and typically processed within 72 hours. A hospital letter confirming the intended treatment is required.
• Patients may apply for a medical visa up to three times per year.
• The electronic medical visa cannot be extended or converted to a tourist or business visa.
• Proof of financial means to cover medical expenses and a return travel ticket may be requested.
• Each applicant must apply individually; no group medical visa exists.
• The passport presented must be valid for at least six months from the date of arrival and contain at least two blank pages.
• Diplomatic, service, official, or refugee passports are not eligible for the Indian Medical Visa.
• For treatment anticipated to exceed 180 days, a conventional paper visa application through the Indian Embassy or High Commission is required.

GHO's patient coordination team prepares all necessary documentation and assists with visa invitation letters as part of the standard service, removing administrative burden from patients and their families at what is already a demanding time.

Types of Bone Marrow Transplant

The appropriate transplant type is determined by the patient's diagnosis, the availability of a suitable donor, and clinical assessment by the transplant team.

Autologous Transplant

In an autologous transplant, the patient's own stem cells are collected and preserved before high-dose chemotherapy or radiation therapy is administered. Once treatment is complete and the bone marrow has been cleared, the preserved stem cells are reintroduced into the body, where they restore immune function and blood cell production. This approach eliminates the risk of donor rejection and is commonly used in the treatment of myeloma and certain lymphomas.

Allogeneic Transplant

An allogeneic transplant uses stem cells from a genetically compatible donor, most commonly a sibling, though parents, other family members, or unrelated matched donors may also be suitable. The donor's cells are evaluated through specialised testing to confirm compatibility. Beyond replacing damaged marrow, donor cells can actively target and destroy residual cancer cells, an effect known as the graft-versus-tumour response.

Umbilical Cord Blood Transplant

Stem cells collected from a newborn's umbilical cord at birth represent a third source for transplantation. These cells mature rapidly and are stored in cord blood banks for future use. They are particularly useful where a matched adult donor cannot be identified, and they carry a lower risk of severe graft-versus-host disease.

Pre-Operative Preparation

Before the transplant proceeds, the patient undergoes a comprehensive evaluation spanning several days. This assessment examines overall organ function, confirms the patient's physical readiness for the procedure, and informs the conditioning plan that will precede the transplant.

A central venous catheter is placed in a large vein in the neck or chest. This central line remains in place throughout treatment and is used to administer stem cells, medications, and blood products, removing the need for repeated venous access.

During this preparatory period, the patient is admitted to a dedicated transplant unit where infection risk is minimised. Because conditioning treatment significantly suppresses the immune system, the clinical environment is carefully controlled.

Stem Cell Collection: Autologous

Where the patient's own cells are to be used, stem cell collection is performed through a process called apheresis. Growth factor injections are administered in the days preceding the procedure to stimulate stem cell production and mobilise cells into the bloodstream. Blood is drawn, passed through a cell-separation machine, and the stem cells are extracted and frozen for use following conditioning treatment.

Stem Cell Collection: Allogeneic

For an allogeneic transplant, stem cells are collected from the confirmed donor, either from bone marrow or from peripheral blood, depending on clinical preference. In cases where cord blood is being used, the banked sample is retrieved and prepared. The transplant team determines the optimal collection method based on individual circumstances.

The Transplant Procedure

Once pre-transplant assessments are complete, the patient begins conditioning. This phase typically involves high-dose chemotherapy, radiation, or a combination of both, and serves three purposes: eliminating remaining cancer cells, suppressing the immune system to reduce the risk of rejection, and creating space within the bone marrow for the incoming stem cells.

Reduced-intensity conditioning may be appropriate for older patients or those with other health considerations. While it uses lower doses, it remains effective at suppressing the immune system and enabling engraftment, with the donor's immune cells continuing to target cancer cells after transplant.

Common side effects during conditioning include nausea, diarrhoea, hair loss, and mouth soreness. The transplant team prescribes targeted medication to manage these effects throughout the process.

The transplant itself is administered intravenously through the central line, in a process comparable to a blood transfusion. It is painless, and the patient remains fully awake throughout. The infused stem cells travel through the bloodstream to the bone marrow, where they begin to establish and multiply, a process called engraftment.

Engraftment typically occurs between 10 and 28 days following the transplant. A rising white blood cell count is the first measurable indicator that the new marrow is functioning. Full restoration of blood cell counts generally follows over the subsequent weeks, though the timeline varies by patient and condition.

Post-Operative Care and Monitoring

The weeks following a bone marrow transplant require close and continuous clinical oversight. The transplant team monitors blood counts, organ function, and signs of complications through regular testing throughout the hospital stay and beyond.

• Autologous transplant patients typically remain in hospital for approximately three weeks; allogeneic transplant patients for approximately four weeks, with extensions possible depending on individual progress.
• International patients are strongly advised to remain in India for 90 to 100 days following the transplant, enabling the transplant team to monitor engraftment, manage complications, and respond to any changes in condition.
• Blood and platelet transfusions may be required during the early recovery period until the new marrow is producing sufficient cells independently.
• The immune system remains significantly suppressed for three months to one year following transplant, during which the patient is at elevated risk of infection. Prophylactic medications are prescribed and hygiene protocols are strictly observed.
• For allogeneic transplants, immunosuppressant medications are prescribed to prevent graft-versus-host disease, a condition where donor cells recognise the patient's body as foreign and mount an immune response.

Full recovery from a bone marrow transplant typically takes around three months, though complete restoration of immune function can take up to a year. Regular follow-up appointments are scheduled throughout this period to track progress and address any emerging concerns.

Recovery Guidance and Long-Term Wellbeing

The recovery period following a bone marrow transplant requires sustained attention to health, nutrition, and infection prevention. Patients and their caregivers are guided by the transplant team throughout this phase, but the following principles apply broadly:

• Adhere strictly to the nutrition plan developed by the transplant dietitian. Dietary adjustments may be needed to manage weight, fluid retention, and any metabolic effects of long-term immunosuppression.
• Take all prescribed medications consistently, including immunosuppressants and infection prophylaxis, for as long as clinically indicated.
• Maintain careful hygiene practices and avoid close contact with individuals who have active infections, particularly during the first year.
• Attend all scheduled follow-up appointments. These consultations allow the transplant team to monitor engraftment quality, immune reconstitution, and any late complications.
• Expect a gradual return to strength and energy. Fatigue, reduced appetite, and changes in taste and smell are common in the early recovery period and improve progressively over time.
• Return to light activities as directed by the treating physician. Full return to work and normal daily life typically becomes possible within 6 to 12 months for most patients.

How GHO Supports Your Journey

At Global Health Opulence, our role extends far beyond connecting patients to hospitals. We manage the full arc of the medical journey, from first contact through to post-treatment follow-up, with the rigour and discretion expected of a premium medical concierge.

For bone marrow transplant patients, our coordination services include:

• Free initial consultation and specialist second opinion facilitation.
• Matching with the most appropriate transplant centre and haematology team based on diagnosis, transplant type, and patient profile.
• Medical visa invitation letters and full documentation support.
• Airport transfers, accommodation arrangements near the treatment centre, and local transport throughout the stay.
• A dedicated patient care coordinator available around the clock for the duration of the medical stay.
• Medical records translation and interpreter support where required.
• Post-treatment virtual follow-up for 30 days (Signature Care Package) or 90 days (Luxe Care Package).

Patients selecting the Luxe Care Package benefit from a VIP care manager, premium hospital suite upgrade, luxury accommodation, and access to wellness and recovery services, all coordinated through a single point of contact.

To begin your consultation, reach out via WhatsApp or visit globalhealthopulence.com. Our team responds within hours.

Frequently Asked Questions